CoreCap Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
47,921
+1,058
+2% +$247K 0.36% 49
2026
Q1
$11.5M Buy
46,863
+900
+2% +$210K 0.39% 50
2025
Q4
$9.51M Buy
45,963
+25,102
+120% +$4.96M 0.33% 52
2025
Q3
$3.87M Buy
20,861
+2,950
+16% +$505K 0.14% 150
2025
Q2
$2.74M Sell
17,911
-1,090
-6% -$168K 0.11% 175
2025
Q1
$3.15M Buy
19,001
+1,334
+8% +$209K 0.14% 146
2024
Q4
$2.55M Buy
17,667
+1,318
+8% +$204K 0.12% 175
2024
Q3
$2.65M Buy
+16,349
New +$2.6M 0.12% 173
2024
Q2
Sell
-15,229
Closed -$2.41M 2138
2024
Q1
$2.41M Buy
15,229
+1,364
+10% +$217K 0.13% 159
2023
Q4
$2.17M Sell
13,865
-649
-4% -$99.5K 0.14% 140
2023
Q3
$2.26M Buy
14,514
+160
+1% +$26.4K 0.16% 125
2023
Q2
$2.38M Buy
+14,354
New +$2.32M 0.17% 111
2022
Q4
$5.07M Buy
28,682
+2,566
+10% +$443K 0.36% 52
2022
Q3
$4.27M Buy
26,116
+2,355
+10% +$399K 0.36% 56
2022
Q2
$4.22M Buy
23,761
+1,750
+8% +$312K 0.33% 58
2022
Q1
$3.9M Buy
22,011
+9,360
+74% +$1.59M 0.27% 68
2021
Q4
$2.16M Buy
+12,651
New +$2.07M 0.14% 118

Other funds holding JNJ

CoreCap Advisors's JNJ Position: Q2 2026 in Review

CoreCap Advisors increased its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, buying an estimated $247K and bringing the position to 47,921 shares worth $12.2M. The position accounts for 0.36% of the portfolio, ranked #49.

CoreCap Advisors first reported a position in JNJ in Q4 2021 and has held it in 17 quarters since. 1,332 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • CoreCap Advisors held 47,921 shares of Johnson & Johnson worth $12.2M as of Q2 2026.
  • CoreCap Advisors bought 1,058 Johnson & Johnson shares in Q2 2026, an estimated $247K.
  • Johnson & Johnson made up 0.36% of CoreCap Advisors's portfolio in Q2 2026, its #49 holding.
  • CoreCap Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 17 quarters since.
  • 1,332 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.